expert id field answers a1 - society of toxicology · expert id field answers a1 primary interest:...

Expert ID Field Answers

A1 Primary Interest: Biological Modeling

Additional Interest(s): Risk Assessment, Inhalation and Respiratory Toxicology

Employment: Academia

Prefers discussing: Research Discipline

Background:

Extensive experience in modeling of chemical kinetics, PBPK modeling, and

other mechanistic modeling, with applications to risk assessment

Meet time: Monday 1:00 pm; Tuesday 1:00 PM

A2 Primary Interest: Biological Modeling

Additional Interest(s): Mechanisms, Risk Assessment

Employment: Other

Prefers discussing: Employment Sector and Research Discipline

Background:

Over 35 years of laboratory and human health risk assessment (RA) at EPA

and RTI. Systems biology focus. Four years experience with CWAE

Meet time: Tuesday 12:10

B1 Primary Interest: Biotechnology

Additional Interest(s): Regulatory and Safety Evaluation, Drug Discovery Toxicology;

Employment: Industry


Background:

Research Scientist, Toxicology at a premier CRO. I serve as a Study Director

and is responsible for design, conduct, interpretation, and reporting of GLP

and non‐GLP preclinical toxicology studies of potential drug candidates in

rodents, canines, and non‐human primates. Recently earned PhD in

Pharmaceutical Sciences in December 2015. Graduate research focused on

characterizing the regulation of Fibroblast growth factor (Fgf) 21 and its

pharmacological/toxicological implications and a prior Bachelorâ€™s

degree in Pharmacy from India. Reviewer for peer‐reviewed journals and is

actively involved in various groups/sections and programs within SOT.

Keen interest and passion to contribute and give back to the scientific

community as well as mentor upcoming graduate students.

Meet time: TBD

B2 Primary Interest: Biotechnology

Additional Interest(s): Mixtures, Cardiovascular Toxicology



Background: Investigating transcriptional regulation of genes after xenobiotics

Meet time: Monday 10:30, Tuesday 10:30, Wednesday 10:30

C1 Primary Interest: Comparative & Veterinary Toxicology

Additional Interest(s): Not Specified



Background:

Gestational bisphenol exposures in large mammals and in vitro exposures

in primary cells (metabolic and placental focus)

Meet time: Monday 12:30

C2 Primary Interest: Comparative & Veterinary Toxicology

Additional Interest(s): Drug Discovery Toxicology, Food Safety

Employment: Government


Background:

Currently work in Chemical and biological defense program management. I

support integration on studies across several programs to ensure

coordination of in vivo and in vitro studies toward medical countermeasure

development.

Meet time: Wednesday 5:00

D1 Primary Interest: Carcinogenesis

Additional Interest(s): Molecular Biology, Regulatory and Safety Evaluation



Background:

Professor of Pharmacology and Toxicology, Michigan State University ‐

Research Interests: Epigenetic mechanisms underlying carcinogenesis,

safety assessment of non‐genotoxic rodent carcinogens ‐ Advisory Boards,

examples: Board of Scientific Councilors, National Toxicology Program;

Board of Scientific Councilors; National Institute of Environmental Health

Sciences, Education Sub‐Committee, European Societies of Toxicology

(EUROTOX) ‐ Society of Toxicology: President (1999‐2000), Merit Award

Recipient (2014)



Additional Interest(s): Drug Discovery Toxicology, Mechanisms



Background:

Development of chemopreventive cancer gents; Lung cancer research;

Perinatal Carcinogenesis



Additional Interest(s): Drug Discovery Toxicology, Reproductive and Developmental Toxicology



Background:

American board certified Toxicologist/ Pharmacologist working in the

pharmaceutical industry for about 20 years in the areas of drug discovery,

nonclinical drug development and nonclinical regulatory submissions. I am

experienced in designing, planning and monitoring, and data interpretation

of toxicology and pharmacology studies to support selection of preclinical

candidates, IND and NDA submissions and in writing nonclinical sections of

the IND and NDA regulatory documents. Studies I have conducted include

in vitro and in vivo ADME (absorption, distribution, metabolism and

excretion) and PK studies, general toxicology, genetic toxicology,

reproductive toxicology, juvenile toxicology, long‐term carcinogenicity and

safety pharmacology studies of several drugs candidates (small/large

molecules, peptides/protein) belonging to various therapeutics areas (GI

diseases, oncology, pain, inflammation, bone diseases). Worked with CROs

to conduct, complete and finalize GLP PK, ADME, safety pharmacology, and

toxicology studies for regulatory submissions. Worked effectively in

project teams/core teams as preclinical expert in setting timelines based

on project/company goals, prioritizing studies needed and completion of

work on time. Participated in due diligence activities of pharmaceuticals for

in‐licensing and research purposes to support Business Development and

Market Research. Managed, supervised and mentored junior staff.


E1 Primary Interest: Dermal Toxicology

Additional Interest(s): In Vitro and Alternative Methods, Regulatory and Safety Evaluation



Background:

Principal scientist at Dstl in the UK. Primarily interested in the

percutaneous penetration of toxic chemicals.


F1 Primary Interest: Drug Discovery Toxicology

Additional Interest(s): Regulatory and Safety Evaluation, Risk Assessment



Background: Computational chemistry, cheminformatics, drug discovery, software design



Additional Interest(s): Reproductive and Developmental Toxicology, Regulatory and Safety Evaluat



Background:

Principal Scientist of Pfizer DSRD in Cambridge, MA. As a Drug Safety

Subject Matter Expert, DSTL (Drug Safety Team Lead), he represents drug

safety within project teams in multiple therapeutic areas and functions;

and provides nonclinical safety strategy in support of both GLP/non‐GLP

toxicity and efficacy studies in drug development and safety. Hank

received his M.S. in Toxicology from National Taiwan University in Taiwan

(1999) and his M.S. and Ph.D. in Pathology and Laboratory Medicine from

University of Rochester Medical School in Rochester, NY (2007) where he

initiated his professional interests in metabolic syndrome and reproductive

endocrinology. Currently he is in the D'Amore‐McKim School of Business

at Northeastern University to obtain the Master in Business

Administration, with specialty in HealthCare management.



Additional Interest(s): Biotechnology, Regulatory and Safety Evaluation



Background:

Works with a non profit Contract Research Organization called Battelle.

Joined Battelle as a Principal Reserarch Scinetist and Study Diretcor in Sept

20015 immediately after my PhD. I have a background of Veterinary

Science and Veterinary Pathology. I would be happy to discuss on

questions on any topic ranging from life in non profit CRO, how to prepare

for a job during PhD, keys of job search, appearing for personal interviews

etc.

Meet time: TBD


Additional Interest(s): Mechanisms, Regulatory and Safety Evaluation



Background:

I am a senior director and currently lead the nonclinical toxicology group at

Genentech (~50 staff) who perform drug discovery lead optimization,

investigative and regulatory functions. I am also a board certified

veterinary pathologist. I have been in the industry for 20 years.

Meet time: Monday 10:00, Tuesday 1:00


Additional Interest(s): Mechanisms



Background: Decades in academia; directs a graduate program; interest in liver toxicology




Employment: Consultant


Background:

20 years in drug development toxicology, 30+ years in toxicology overall

(including CROs)


G1 Primary Interest: Ethical, Legal and Social Issues

Additional Interest(s): Mixtures, Risk Assessment

Employment: Other


Background: I have 40 years in the field of chemical risk assessment. My current research


H1 Primary Interest: Food Safety




Background:

I have spent over 30 years as a corporate toxicologist working in the

chemicals, pesticides, excipeints and food additive safety issues and the

last 9 years as a consultant. My background is toxicology for regulatory

decision making, risk assessment and food safety. I am a DABT and Fellow

of ATS.

Meet time: Tuesday 12:15, Wednesday 12:15





Background:

I have been working in the consumer packaged goods industry supporting

both household chemicals as well as food safety.



Additional Interest(s): Dermal Toxicology, Risk Assessment

Employment: Acadmia


Background:

Extensive experience in toxicology in industry/academy/consulting for

government and industry. Knowledgeable about publishing [editor in chief

of several journals and Hayes' Principles and Methods of Toxicology


I1 Primary Interest: Immunotoxicology

Additional Interest(s): Reproductive and Developmental Toxicology, Neurotoxicology



Background:

Basic research scientist in academia who completed a federal government

postdoc and who mainly studies PFASs.



Additional Interest(s): In Vitro and Alternative Methods, Neurotoxicology



Background:

Industry investigative tox. Toxin mechanisms. Immunotoxicity and

protection. Vaccines study director.






Background:

>20 years in the biopharmaceutical industry with expertise in biologics

drug development and immunotoxicology.



Additional Interest(s): Molecular Biology, Biotechnology



Background:

Columbia. My area of research includes Mol Immunology, Epigenetics, and

Immmunotoxucity.



Additional Interest(s): Mechanisms, Neurotoxicology



Background:

I am a Professor of Pharmacology and Cancer Biology at Duke University

Medical Center and of Neurobiology. The focus of the proposed study is

the development of serum biomarker for neural injury in an animal model

that we previously developed, for the Gulf War Veteransâ€™ illnesses. This

includes diagnostic studies of long term consequences of nervous system

injury from various causes. I obtained his Ph.D. from the University of

California at Berkeley. I am a Certified Toxicologist by both the American

Board of Toxicology and the Academy of Toxicological Sciences. I edited

two books â€œNeurotoxicologyâ€ and Mammalian Toxicology.

Meet time: Monday 10:00 pm

J1 Primary Interest: In Vitro and Alternative Methods

Additional Interest(s): Drug Discovery Toxicology, Risk Assessment



Background: Associate Research Director, Syngene International Ltd, e.mail: Sonali.Das@



Additional Interest(s): Stem Cells, Cardiovascular Toxicology



Background:

Principal Investigator at the National Center for Toxicological Research, US

FDA, where she serves as the PI of three NCTR protocols, one of which is

supported by the FDA Office of Womenâ€™s Health and two are supported

by the FDA Center for Drug Evaluation and Research (CDER). Her current

research interests include studying sex differences in drug‐induced QT

prolongation and Torsade de Pointes, developing early biomarkers for

radiation‐induced heart disease, and using iPSC‐hCMs model for drug‐

induced cardiotoxicity detection. She received her doctorate in clinical

medicine from North China Coal Medical College in 1993 and was a

postdoctoral fellow at the Montreal Heart Institute from 2000‐2004.

Before joining the FDA, Dr. Pang was a faculty member of the Department

of Pharmacology & Toxicology at the University of Arkansas for Medical

Sciences, where she served as the PI of a NHLBI‐funded RO1 project. She is

author/co‐author of 16 peer‐reviewed articles and her work has been cited

for more than 900 times. Dr. Pang has been a member of the SOT since

2015 and is a member of Cardiac Safety Research Consortium since 2014.



Additional Interest(s): Inhalation and Respiratory Toxicology, Medical Device

Employment: Other


Background:

PhD in Cellular and Molecular Biology; Current President of SOTâ€™s In

Vitro and Alternative Methods Specialty Section.

Meet time: Monday 7:00, Thursday 7:00


Additional Interest(s): Mechanisms, Carcinogenesis



Background:

I have been a professor of toxicology for nearly 40 years at a major

research university (Univ. Washington). I currently serve as Dean and Vice

Provost of the Graduate School for all of UW. I have been involved with

SOT my entire career, and served as President in 2001. I Received the SOT

Achievement Award, and the Public Communications Award, and was

Elected to the National Academy of Medicine in 2011.



Additional Interest(s): Risk Assessment, Food Safety

Employment: Other


Background:

I am a Toxicologist at a contract research organization called Integrated

Laboratory Systems, Inc. where we support the NTP Interagency Center for

the Evaluation of Alternative Toxicological Methods (NICEATM). My work

focuses on promoting the development, validation, acceptance, and use of

alternative and revised testing methods. I have a PhD in Biochemistry and

Toxicology from Michigan State University, after which I did a government

postdoc the US EPAâ€™s National Center for Computational Toxicology

working with the ToxCast high‐throughput screening program.



Additional Interest(s): Mechanisms, Clinical and Translational Toxicology



Background:

I am with FDA NCTR and I have a focused research area: mechanisms and

biomarkers for DILI. I have more than 15 yearsâ€™ experience in

culture of primary hepatocytes from multiple species with a

mechanistic focus on drug induced mitochondrial damages and

metabolism‐mediated hepatocyte injury. For biomarker studies, I use

both animal models and human clinical samples to explore novel

translational DILI biomarkers, focusing on circulating microRNAs in the

urine and blood.



Additional Interest(s): Drug Discovery Toxicology, Mechanisms



Background:

26 years experience in cytotoxicity assay development used for high

throughput screening.



Additional Interest(s): Regulatory and Safety Evaluation, Dermal Toxicology



Background:

I have collabolations with a few universities and assit the studesnts for

research field. On the other hand, I teached the in vitro toxicology or

safety assessment of cosmetic in severeal univesities as a visitig professor.

Meet time: Monday 1:00, ,Tuesday 1:00

K1 Primary Interest: Inhalation and Respiratory Toxicology

Additional Interest(s): Regulatory and Safety Evaluation, Biotechnology



Background:

Worked for Gov't (EPA), Industry (Genetech, Bayer) and currently an

independent consultant.



Additional Interest(s): Clinical and Translational Toxicology, Occupational Health



Background:

Discovering health effects of air pollution exposures using in vitro cell, in

vivo rodent and human exposures.



Additional Interest(s): Regulatory and Safety Evaluation, Occupational Health



Background: I am a consultant with history performing inhalation animal safety studies.



Additional Interest(s): Mechanisms, Molecular Biology



Background:

Inhalation biology ‐ exposure biology to human and rodents in relation to

toxicology in the pathogenesis of chronic lung diseases and oral diseases.


L1 Primary Interest: Mechanisms

Additional Interest(s): Metals, Neurotoxicology

Employment: Other


Background:

My background is multivaried and my pathway was NOT a straight line.

Toxicology is my 2nd career, proving it's never too late for a change.



Additional Interest(s): In Vitro and Alternative Methods, Nanotoxicology



Background:

Molecular Toxicologist ‐ use functional approaches to understand

mechanisms of toxicity.

Meet time: Monday 12:00, Tuesday 12:00, Wednesday 12:00, Thursday 12:00


Additional Interest(s): Nanotoxicology, Toxicologic Pathology & Exploratory Pathology



Background:

I am a career academic who has worked in both high‐profile and low‐

profile research institutions; knows how to balance teaching & research; I

can share my experience with anyone interested in learning how to land in

well‐paying academic job (TT/ non TT or similar). My accomplishments can

be found at the URL: sidhartharay.com. I have mentees throughout the US.

Meet time: Monday 2:00, ,Tuesday 2:00


Additional Interest(s): Immunotoxicology, Food Safety



Background: Had been working in toxicology for the last thirty five year.



Additional Interest(s): Carcinogenesis, Stem Cells



Background:

I am an academic scientist with broad research interests in mechanisms of

liver injury, regeneration, cancer and use of bioinformatics to solve

mechanistic problems. I am originally from India, did my PhD here in the

US and now have my own laboratory.

Meet time: TBD

M1 Primary Interest: Medical Device

Additional Interest(s): Risk Assessment, Clinical and Translational Toxicology



Background:

Medical device Toxicologist with extensive analytical chemistry and

pharmacology background.


N1 Primary Interest: Metals

Additional Interest(s): Carcinogenesis, Molecular Biology



Background: Understanding the role of metal deregulation in cancer, esp with analysis me


O1 Primary Interest: Mixtures

Additional Interest(s): Metals, Inhalation and Respiratory



Background: Grant Program Administrator at NIEHS and the NIEHS Superfund Research P


P1 Primary Interest: Molecular Biology

Additional Interest(s): Mechanisms, In Vitro and Alternative Methods



Background: Epigenetics, in vitro models, and clinical/translational toxicology.


Q1 Primary Interest: Nanotoxicology

Additional Interest(s): In Vitro and Alternative Method

Employment: NGO


Background:

A nanotoxicology specialist for the PETA International Science Consortium

Ltd. She received her Ph.D. in Biomedical Sciences from Wright State

University with Nanotoxicology as the main area of focus. As the

Nanotoxicology Specialist at the PETA International Science Consortium

Ltd., She researches and promotes human‐relevant non‐animal methods to

assess nanotoxicity. She participates on the International Organization for

Standardization (ISO) Technical Committee on nanotechnology and the

Organization for Economic Co‐operation and Development Working Party

for Manufactured Nanomaterials (OECD WPMN) to ensure the best non‐

animal methods are included in international standards and guidelines for

nanomaterial testing.



Additional Interest(s): In Vitro and Alternative Method, Inhalation and Respiratory



Background: Development of 3D in vitro models.



Additional Interest(s): Inhalation and Respiratory, Immunotoxicology



Background:

Professor and Director of the Toxicology Graduate Program at NC State

University. He research interests are in nanotoxicology, lung biology and

immunology. He has broad career experience in toxicology from working in

government, non‐profit, industry and academia.



Additional Interest(s): Carcinogenesis, In Vitro and Alternative Methods



Background:

My primary research focus is using both in vitro and in vivo methods to

assess pulmonary toxicity risk of engineered nanomaterials, including

carbon nanotubes, metal oxides, and nanoclays. Within these studies, my

group evaluates potential for chronic diseases including carcinogenesis and

fibrosis, and their underlying mechanisms. I have a broad environmental

toxicology background including pulmonary toxicology, lung cancer, and

aquatic ecotoxicology.


R1 Primary Interest: Neurotoxicology

Additional Interest(s): Stem Cells, Metals



Background:

My lab studies gene x toxicant interactions (especially metals) in the

context of neurological disease.



Additional Interest(s): Drug Discovery Toxicology, Clinical and Translational Toxicology



Background:

My research explores the mechanisms by which nerve agents affect the

central nervous system.






Background:

Recently tenured neurotoxicologist who studies environmentally‐induced

neurodegeneration.



Additional Interest(s): Clinical and Translational Toxicology, Cardiovascular Toxicology



Background:

Pharmacologist/toxicologist with emphasis on CNS; translational tox;

animal models; developmental neurotox of pediatric anesthetics.



Additional Interest(s): Reproductive and Developmental Toxicology, Stem Cells



Background:

Director of the National Center for Toxicological Research/FDA. Research

interests include developmental neurotoxicology and biomarker

development. Past president of SOT, ATS and Teratology.

Meet time: Monday 2:00, Tuesday 2:00, Thursday 9:00


Additional Interest(s): Mechanisms, Metals



Background: Undergraduate educator who also has an active, funded research lab.

Meet time: TBD

S1 Primary Interest: Occupational Health




Background: Board‐certified toxicologist versed in risk assessment. Experienced in produc


T1 Primary Interest: Ocular Toxicology




Background: I have been involved in nonclinical ocualr toxicology for over 15 years. In ad

Meet time: Wednesday 10:00, Thursday 10:00

U1 Primary Interest: Regulatory and Safety Evaluation

Additional Interest(s): Dermal Toxicoloy; Carcinogenesis

Employment: Other


Background:

I have spent more than 40 years in the CRO industry and am familiar with

regulatory and safety evaluation issues in a wide variety of areas. I have

presented nationally and internationally on Study Director issues.



Additional Interest(s): Risk Assessment,



Background:

I have expertise in both traditional and structure‐activity‐relationship

based read‐across hazard and risk assessment of chemicals, as well as in

global chemical registration regulations such as EU REACH.



Additional Interest(s): In Vitro and Alternative Methods, Risk Assessment



Background: ERT working in biotech industry as a Product Stewarsdship/Regulatory Speci



Additional Interest(s): Clinical and Translational Toxicology, Food Safety



Background:

Hands‐on experience with management of both pre‐clinical and clinical

toxicologic research, submission of both food additive petitions and GRAS



Additional Interest(s): Risk Assessment, Reproductive and Developmental Toxicology



Background:

Use of toxicological sciences to support safe use of petrochemical

products. Design, conduct and evaluation of toxicology studies.

Communication of results to internal and external audiences.



Additional Interest(s): Risk Assessment, Inhalation and Respiratory Toxicology



Background:

Received my PhD in molecular carcinogenesis, working as a toxicologist for

a Texas environmental regulator.



Additional Interest(s): Risk Assessment

Employment: Other


Background:

Responsible for providing technical support on the science and regulation

of personal care products.






Background: Regulatory Toxicology; Product Safety; Product Stewardship.






Background: Pesticide toxicology/risk assessment & registration with US EPA



Additional Interest(s): Clinical and Translational Toxicology, Drug Discovery Toxicology



Background:

Board certified toxicologist with >25 years of research experience in

toxicology and over 24 years experience in the pharmaceutical industry

with extensive experience in the development of new molecular entities,

medical devices, reformulations of marketed products and global product

registration and support.



Additional Interest(s): Cardiovascular Toxicology, Molecullar Biology



Background:

Major in Pharmacology & Toxicology; Working in systems biology area

including transcriptomics, proteomics, metabolomics and epigenetics;

Mainly conduct bioinformatic analysis using SAS, R, JMP and Pathway

analysis.



Additional Interest(s): Risk Assessment, Dermal Toxicology



Background:

Industrial toxicologist with over 15 years of experience in large Pharma and

Vaccines.



Additional Interest(s): Clinical and Translational Toxicology, Drug Discovery Toxicology

Employment: Other


Background:

35+ years' experience at a large non‐profit CRO doing drug development

across many disease areas.



Additional Interest(s): In Vitro and Alternative Methods, Risk Assessment



Background:

Regulatory scientist in safety assessment of toxicological data. Review and

provide assessment on risk assessment, modeling, in‐vitro and alternative

testing, coordinate testing startegy with CROs, interphase with EPA and

marketing division, prepare dossiers for regulatory submissions.



Additional Interest(s): Risk Assessment, Mixtures



Background:

I'm a Senior Toxicologist at an Environmental Health consulting firm

(Gradient) who's primary areas of expertise include mode of action, risk

assessment, chemical hazard assessment, and toxicity criteria

development.



Additional Interest(s): Reproductive and Developmental Toxicology, Drug Discovery Toxicology



Background:

Completed undergraduate work in marine biology in Colombia, a MS in

environmental toxicology and a PhD in toxicology from the University of

Maryland.Currently a Pharmacology and Toxicology reviewer for oncology

and benign hematology drug products in the US FDA‐CDER. He has worked

in early discovery, lead optimization and nonclinical development of small

molecule pharmaceuticals and biologics. As a study director, he conducted

general toxicology, carcinogenicity and Developmental and Reproductive

Toxicology nonclinical studies and has more than 20 years of experience in

GLP. He conducts peer review of articles for the International Journal of

Toxicology.



Additional Interest(s): Food Safety, Risk Assessment



Background: Toxicologist in the Food Industry with prior experience in contract research



Additional Interest(s): Immunotoxicology, Drug Discovery Toxicology



Background:

25+ years of drug development experience with major pharma in CV,

metabolic diseases, oncology, immunology and inflammation.



Additional Interest(s): Drug Discovery Toxicology, Carcinogenesis



Background:

I am a senior project toxicologist at Bristol‐Myers Squibb working on a

variety of drug development programs including small molecules, biologics

and antibody drug conjugates.



Additional Interest(s): Dermal Toxicology, Stem Cells

Employment: Other


Background:

Director, Photobiology and Cellular Therapeutic Safety. 28 years of

pharma and CRO experience.



Additional Interest(s): Drug Discovery Toxicology, In Vitro and Alternative Methods



Background:

35 years pharmaceutical drug discovery and development expertise with

major pharma companies.






Background:

I am an independent toxicology consultant who works with companies in

the pharmaceutical, food and chemical industries to assist with their

regulatory toxicology needs.


V2 Primary Interest: Reproductive and Developmental Toxicology

Additional Interest(s): Molecular Biology, Mechanisms

Employment: Goverrnment


Background:

Toxicity assessment of products of interest to the FDA. Characterization of

novel biomarkers of toxicity.



Additional Interest(s): Regulatory and Safety Evaluation,



Background:

I have been working in the commercial sector for over 40 years and as a

consultant 35. My focus is regulatory developmental and reproductive

toxicology.



Additional Interest(s): Regulatory and Safety Evaluation, Neurotoxicology



Background:

I am an FDA expert in infant toxicology and lifestage‐specific safety

assessment. I have a PhD in toxicology with a specialization in

developmental neurotoxicology and certification in risk sciences and public

policy.



Additional Interest(s): Mechanisms, In Vitro and Alternative Methods



Background:

I recieved my PhD in toxicology form University of Michigan. I also have an

MPH and Biomedical Engineering degress from Universtiy of Minnesota. I

have worked in risk assessment for a state health department. I also have

extensive research experience. I am currently a postdoctoral fellow at the

USEPA.



Additional Interest(s): Molecular Biology, Neurotoxicology



Background:

My expertise in the area of developmental toxicology using Japanese

medaka fish as my experimental model. We have used medaka embryos

for epigentic assessment of the developmental disorder induced by

ethanol and natural products.


W1 Primary Interest: Risk Assessment

Additional Interest(s): Carcinogenesis, In Vitro and Alternative Methods



Background:

Training in carcinogenesis and molecular biology; currently working on

biomonitoring and HTS methods.



Additional Interest(s): Regulatory and Safety Evaluation, In Vitro and Alternative Methods



Background:

My background is on the risk assessment of industrial chemicals and

pesticides. I also actively work on projects assesing the applicability of

alternative methods to animal testing for regulatory purposes.



Additional Interest(s): Regulatory and Safety Evaluation

Employment: NGO


Background:

Human health risk assessment of environmental chemicals; consumer

product safety.



Additional Interest(s): Mixtures, Ethical, Legal, and Social Issues



Background:

My focus is on evaluating health effects of chemicals, determining

exposure limits (e.g., RfDs), and improving methods for doing so, including

dosimetry and use of AOPs. I have worked in academic, consulting, and

nonprofit environments.

Meet time: TBD


Additional Interest(s): Metals, Epidemiology



Background:

Diverse background starting with academia to government to consulting,

experience in practical application of toxicology.

Meet time: Wednesday 7:00, Thursday 7:00


Additional Interest(s): Metals, Epidemiology



Background:

I am currently the Section Head for the Epidemiology, Health Surveillance,

and Quality Assurance (QA) Teams at ExxonMobil Biomedical Sciences, Inc.

(EMBSI). I am responsible for coordinating epidemiology and QA programs

for ExxonMobil global business units and external collaborations. Previous

to my current role, I was Section Head for Toxicology at EMBSI, where I

coordinated all internal toxicology programs. I am actively involved in the

advancement of emerging and progressive risk assessment methods. I

received my PhD in Toxicology from the University of Rochester in 2004 in

the lab of Dr. Thomas A. Gasiewicz.



Additional Interest(s): Ethical, Legal, and Social Issues, In Vitro and Alternative Methods



Background:

Currently a consultant; expertise/background is in PBPK modeling and risk

assessment.



Additional Interest(s): Medical Device, Occupational Health



Background:

I am a regulatory tioxicologist with major pharma and write risk

assessment to support combination products, extraneous matter, etc. as

well as set occupational expousre limits for staff for APIs.



Additional Interest(s): Regulatory and Safety Evaluation, Ethical, Legal, and Social Issues



Background:

I am a pharmacologist, toxicologist, human health risk assessor and patent

agent. I work as a consultant in my own company.



Additional Interest(s): Comparative & Veterinary Toxicology, Immunotoxicology



Background: Use various and alternal lab animal models to develop safe levels of exposur


X1 Primary Interest: Toxicologic Pathology & Exploratory Pathology

Additional Interest(s): Immunotoxicology, Biotechnology



Background:

I am trained and experienced in toxicology (general) and veterinary

pathology. I have worked in academic, contract research, and

pharmaceutical industry settings. Outside of toxicology, I workked as a

medical anthropologist and enjoy learning about cultures, cultural

transitions and cross‐cultural engagements.


n and development.

y.

interests are issues related to risks posed by combined exposures to multiple chemicals.

@syngeneintl.com. I have joined Syngene International, one of the leading CROs in Biotech, in August 2016, as an

ethods.

rogram.

ct safety and occupational health in both the consumer goods and pharmaceutical industries.

dition, I have conducted general toxicology studies in support of INDs.

alist.

n Associate Research Director and leading the team Heptox.Prior to joining Syngene I was at Strand Life Sciences

s Pvt Ltd, a bioinformatics company, over a period of 10 years (2006 â€“ present). At Strand I was leading the pr

oject involved in prediction of drug induced liver injury. The DILI prediction platform Heptox is a Systems Biology

y approach to develop a platform to predict Drug Induced Liver Injury (DILI). I was involved from the very beginn

ning of conceiving the idea of this R & D endeavor, developing multiple modules and integrating them into one c

common kinetics‐based model to predict DILI. Heptox team at Strand obtained a nation‐wide competitive fundi

ng ‐ a DBT‐funded programme BIPP, in 2010‐2011 for validation of the DILI prediction platform where I contribu

uted as the Principal Scientist. Based on the performance o

expert id field answers a1 - society of toxicology · expert id field answers a1 primary interest:...

Documents